Stem cell eye drops for dry eye treatment
Part of Bones, joints & muscles, Eyes & vision, Immune system & allergy, Mouth & dental, Skin clinical trials.
This trial tests a new eye drop made from stem cells to see if it can help relieve dry eye symptoms. It is for people with moderate to severe dry eye who haven't had recent eye surgery or used other eye drops.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe dry eye symptoms like burning, itching, or a gritty feeling.
- You are between 18 and 70 years old.
- You haven't had eye surgery before.
- You haven't used contact lenses in the last 3 months.
- You haven't used any eye drops besides artificial tears or lubricating ointments in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental eye drop made from human platelets (blood cells that help healing) for people with moderate to severe dry eye. The drop is compared to a placebo (fake drop) to see if it improves eye comfort and surface health.
This trial tests whether stem cell fortified eye drops can improve tear film stability, tear volume, and dry eye symptoms. If you have dry eye disease and haven't had eye surgery or certain other eye conditions, you may be able to join.
This early-stage trial tests whether special cells derived from umbilical cord tissue can help treat dry eye disease. The treatment uses tiny particles called extracellular vesicles that may reduce eye dryness and improve comfort.
This study tests a new eye drop called CSB-001 for people with limbal stem cell deficiency (LSCD), a condition that damages the cornea. The goal is to see if the drops can help improve the health of the cornea and reduce inflammation.
This study tests whether a special substance from stem cells (called secretome) can help heal chronic surface problems on the eye that haven't gotten better with standard treatments. It's for people with a stubborn scratch or defect on the cornea that has lasted more than 14 days.
This trial tests an eye drop solution for people with chronic dry eye caused by graft-versus-host disease after a stem cell transplant. It aims to see if the drops can reduce eye discomfort and improve the eye surface.
Hear when a new Dry Eye Syndromes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.